Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities

NCT00158041 is registered in ClinicalTrials.gov with Mt. Sinai Medical Center, Miami as lead sponsor.

NCT NCT00158041
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00158041 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Prospective Trial Evaluating the Toxicities Associated With Subcutaneous Administration of Ethyol (Amifostine) for the Prevention of Radiation-Induced Toxicities
Lead sponsor
Mt. Sinai Medical Center, Miami
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2002
Completion date
January 31, 2005
Enrollment
452
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer, lung cancer, lymphoma